Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Counteracting Risperidone-Induced Hyperprolactinemia in Youths

NCT00799383 is registered in ClinicalTrials.gov with Chadi A. Calarge as lead sponsor.

NCT NCT00799383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00799383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Counteracting Risperidone-Induced Hyperprolactinemia in Youths
Lead sponsor
Chadi A. Calarge
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
March 31, 2014
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

risperidone-induced hyperprolactinemia